Royal London Asset Management LTD Royalty Pharma PLC Transaction History

Royal London Asset Management LTD

  • $39.4 Billion
  • Q3 2024

A detailed history of Royal London Asset Management LTD transactions in Royalty Pharma PLC stock. As of the latest transaction made, Royal London Asset Management LTD holds 160,184 shares of RPRX stock, worth $4.98 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
160,184
Previous 155,877 2.76%
Holding current value
$4.98 Million
Previous $4.11 Million 10.24%
% of portfolio
0.01%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$25.63 - $29.27 $110,388 - $126,065
4,307 Added 2.76%
160,184 $4.53 Million
Q2 2024

Aug 07, 2024
SELL
$26.26 - $29.9 $4.82 Million - $5.49 Million
-183,688 Reduced 54.1%
155,877 $4.11 Million
Q1 2024

May 14, 2024
BUY
$27.46 - $31.33 $487,936 - $556,702
17,769 Added 5.52%
339,565 $10.3 Million
Q4 2023

Feb 13, 2024
BUY
$26.21 - $29.22 $86,021 - $95,900
3,282 Added 1.03%
321,796 $9.04 Million
Q3 2023

Nov 14, 2023
BUY
$26.26 - $31.38 $1.38 Million - $1.65 Million
52,524 Added 19.75%
318,514 $8.64 Million
Q2 2023

Aug 11, 2023
BUY
$29.6 - $36.56 $3.66 Million - $4.52 Million
123,566 Added 86.76%
265,990 $8.18 Million
Q1 2023

May 15, 2023
BUY
$32.77 - $39.4 $485,094 - $583,238
14,803 Added 11.6%
142,424 $5.13 Million
Q4 2022

Feb 09, 2023
BUY
$39.17 - $44.04 $298,162 - $335,232
7,612 Added 6.34%
127,621 $5.04 Million
Q3 2022

Nov 14, 2022
SELL
$39.88 - $44.65 $158,682 - $177,662
-3,979 Reduced 3.21%
120,009 $4.82 Million
Q1 2022

May 13, 2022
BUY
$37.46 - $42.44 $221,163 - $250,565
5,904 Added 5.0%
123,988 $4.83 Million
Q4 2021

Aug 16, 2022
BUY
$35.17 - $42.48 $4.15 Million - $5.02 Million
118,084 New
118,084 $4.71 Million
Q4 2021

Jan 18, 2022
SELL
$35.17 - $42.48 $4.15 Million - $5.02 Million
-118,084 Closed
0 $0
Q3 2021

Aug 16, 2022
BUY
$36.14 - $42.24 $4.27 Million - $4.99 Million
118,084 New
118,084 $4.27 Million
Q3 2021

Nov 02, 2021
SELL
$36.14 - $42.24 $4.27 Million - $4.99 Million
-118,084 Closed
0 $0
Q2 2021

Oct 18, 2022
SELL
$39.85 - $46.63 $235,274 - $275,303
-5,904 Reduced 4.76%
118,084 $4.84 Million
Q2 2021

Aug 16, 2022
BUY
$39.85 - $46.63 $4.71 Million - $5.51 Million
118,084 New
118,084 $4.84 Million
Q2 2021

Jul 14, 2021
SELL
$39.85 - $46.63 $4.71 Million - $5.51 Million
-118,084 Closed
0 $0
Q1 2021

Oct 17, 2022
SELL
$42.34 - $52.82 $249,975 - $311,849
-5,904 Reduced 4.76%
118,084 $5.15 Million
Q1 2021

Aug 16, 2022
BUY
$42.34 - $52.82 $5 Million - $6.24 Million
118,084 New
118,084 $5.15 Million

Others Institutions Holding RPRX

# of Institutions
412
Shares Held
284M
Call Options Held
578K
Put Options Held
47.5K
View Full List

About Royalty Pharma plc

RPRX Quotes by TradingView
  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $13.6B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Royal London Asset Management LTD Portfolio

Follow Royal London Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal London Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Royal London Asset Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email